BIOMAT Database Logo BIOMAT Database Logo

In vitro interleukin 2 and natural killer activity in renal allograft recipients. 1987

R J Rigby, and A E Smillie, and K Cheung
Nephrology Department, Princess Alexandra Hospital, Brisbane, Australia.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

R J Rigby, and A E Smillie, and K Cheung
Natural killer-cell activity in cyclosporine-treated renal allograft recipients.
March 1988, Journal of clinical immunology,
R J Rigby, and A E Smillie, and K Cheung
Interleukin-2 reconstitutes natural killer activity in transplant recipients.
February 1989, Transplantation proceedings,
R J Rigby, and A E Smillie, and K Cheung
Natural killer activity in kidney allograft recipients.
September 1981, Transplantation proceedings,
R J Rigby, and A E Smillie, and K Cheung
Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
April 1988, Transplantation proceedings,
R J Rigby, and A E Smillie, and K Cheung
Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
August 1990, Transplantation proceedings,
R J Rigby, and A E Smillie, and K Cheung
Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection.
June 1987, Human immunology,
R J Rigby, and A E Smillie, and K Cheung
Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.
September 1986, Journal of clinical immunology,
R J Rigby, and A E Smillie, and K Cheung
Decrease in natural killer cell activity in kidney allograft recipients.
January 1983, Annales d'immunologie,
R J Rigby, and A E Smillie, and K Cheung
Plasma interleukin 2 receptor levels in renal allograft recipients.
May 1987, Clinical immunology and immunopathology,
R J Rigby, and A E Smillie, and K Cheung
Interleukin-2 augments natural killer cell activity.
May 1981, Nature,
Copied contents to your clipboard!